S-EPMC10430911 - P1149: COMPARISON OF THE EFFICACY OF EPCORITAMAB VERSUS CHIMERIC ANTIGEN RECEPTOR THERAPIES, POLATUZUMAB-BASED REGIMENS, AND TAFASITAMAB-BASED REGIMENS - OmicsDI

Unknown

Dataset Information

P1149: COMPARISON OF THE EFFICACY OF EPCORITAMAB VERSUS CHIMERIC ANTIGEN RECEPTOR THERAPIES, POLATUZUMAB-BASED REGIMENS, AND TAFASITAMAB-BASED REGIMENS

ABSTRACT:

SUBMITTER: Rosenthal A

PROVIDER: S-EPMC10430911 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature